Generate Investment Management Ltd Cuts Position in UnitedHealth Group Incorporated (NYSE:UNH)

Generate Investment Management Ltd lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 34.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 43,918 shares of the healthcare conglomerate’s stock after selling 22,820 shares during the period. UnitedHealth Group comprises approximately 1.7% of Generate Investment Management Ltd’s holdings, making the stock its 20th biggest holding. Generate Investment Management Ltd’s holdings in UnitedHealth Group were worth $25,678,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Swedbank AB purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after purchasing an additional 1,196,758 shares during the period. Lone Pine Capital LLC acquired a new position in UnitedHealth Group in the 2nd quarter worth $480,903,000. Dimensional Fund Advisors LP lifted its stake in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares in the last quarter. Finally, Baillie Gifford & Co. grew its stake in UnitedHealth Group by 1,125.4% during the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after purchasing an additional 821,050 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 0.6 %

UNH stock opened at $569.61 on Friday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $608.63. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $525.99 billion, a price-to-earnings ratio of 37.77, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The firm’s 50-day moving average is $584.42 and its two-hundred day moving average is $533.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.56 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is 55.70%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Stephens decreased their price target on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday. Cantor Fitzgerald increased their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research report on Wednesday. KeyCorp initiated coverage on UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Argus boosted their price target on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, Robert W. Baird lifted their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $615.58.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.